We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
Lexology logo
  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-4 of 4

Private members' bills seek amendments to Patent Act and Food and Drugs Act

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • May 28 2009

A review of certain current private members' bills before Parliament reveal that important changes are being sought to both patent and food and drug legislation

Supreme Court denies leave to appeal in Section 8 damage case

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • February 12 2010

Recently, the Supreme Court denied Apotex's leave application for leave to appeal to the Supreme Court of Canada in respect of Apotex's case seeking damages for alleged delays due to a proceeding brought by Merck under the Patented Medicines (Notice of Compliance Regulations) ("NOC Regulations"

Health Products & Food Branch policy on counterfeit health products

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • May 21 2010

By a document posted May 14, 2010, the Health Products & Food Branch Inspectorate have set out guiding principles of Health Canada's decision making framework for identifying, assessing and managing health risks to identify the issues of counterfeit health products

TPD statistical report 2008 PMNOC Regulations released

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • April 14 2010

On March 17, 2010, the Therapeutic Products Directorate released its annual report for the year 2008 on the Patented Medicines (Notice of Compliance) Regulations ("PMNOC Regulations"